An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trials of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19 (INSIGHT-012_OTAC)

This study will evaluate a treatment strategy for COVID-19 patients with passive immunotherapy plus current standard of care treatment. The goal is to find out if the study drug is safe, and if it will help people stay out of the hospital and have fewer problems caused by COVID-19.